Skip to main content
InspireMD, Inc. logo

InspireMD, Inc. — Investor Relations & Filings

Ticker · NSPR ISIN · US45779A8466 LEI · 549300OQ16IJ5DIS5D30 US Manufacturing
Open in API
Filings indexed 1,108 across all filing types
Latest filing 2026-06-03 Declaration of Voting R…
Country US United States of America
Listing US NSPR

About InspireMD, Inc.

https://www.inspiremd.com/en/

InspireMD, Inc. is a commercial-stage company focused on developing and commercializing technologies for stroke prevention through advanced carotid intervention. The company's core technology is its proprietary MicroNet™ platform, a non-metallic mesh designed to prevent plaque prolapse and embolization. Its flagship product, the CGuard® Prime Carotid Stent System, integrates this MicroNet mesh with a self-expanding nitinol stent. This dual-layered design provides neuroprotection by trapping potential emboli during and after carotid artery stenting procedures. The system is indicated for improving carotid luminal diameter in patients who require carotid revascularization and are at high risk for adverse events from carotid endarterectomy.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K “Current Report” under Items 5.03 and 5.07. Item 5.07 provides the final voting results from the Company’s 2026 Annual Meeting of Stockholders, showing vote counts for proposals. This matches the definition for “Declaration of Voting Results & Voting Rights Announcements” (Code: DVA), which covers official vote results at a general meeting.
2026-06-03 English
8-K
Board/Management Information Classification · 90% confidence The document is a Form 8-K “Current Report” under the Exchange Act, specifically Item 5.02 describing the departure of a Class I director and related Board succession planning. This clearly falls under announcement of changes in the company’s board of directors or senior management, matching the Board/Management Information category.
2026-05-22 English
10-Q - InspireMD, Inc. (0001433607) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-07 English
ARS - InspireMD, Inc. (0001433607) (Filer)
Annual Report
2026-04-20 English
8-K - InspireMD, Inc. (0001433607) (Filer)
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated April 3, 2026, by InspireMD, Inc. It reports the entry into a material definitive agreement, specifically an Equity Distribution Agreement with BTIG, LLC, for an at-the-market offering of common stock. The document details the terms of the agreement, the termination of a prior equity distribution agreement, and includes exhibits such as the agreement itself and legal opinions. There are no financial statements or comprehensive financial data presented, nor is this a report of earnings or annual performance. The content focuses on a capital raising transaction and related agreements. Therefore, this filing is best classified as a Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about the financing activity, not just an announcement or a brief notice.
2026-04-03 English
424B5 - InspireMD, Inc. (0001433607) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement and base prospectus related to an equity distribution agreement for the sale of common stock. It includes detailed information about the offering, risk factors, use of proceeds, plan of distribution, and legal matters. The document is filed pursuant to Rule 424(b)(5), which is a SEC rule for prospectus supplements related to securities offerings. The content focuses on capital raising activities and the terms of the stock offering rather than financial results, management changes, or other report types. Therefore, this document is best classified as a Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief summary, so it is not an RPA or FS. Confidence is high given the clear nature of the document as a prospectus supplement for a stock offering.
2026-04-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.